Frequency Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Korro Bio

12/08/2021 14:18

* Frequency Therapeutics Inc  FREQ.OQ  reported a quarterly
adjusted loss of 52 cents​​ per share for the quarter ended in
June. The mean expectation of five analysts for the quarter was
for a loss of 51 cents per share.
* Revenue rose 10.5% to $9.42 million from a year ago;  analysts
expected $6.71 million. 
* Frequency Therapeutics Inc's reported EPS for the quarter was
a loss of 52 cents​.
* The mean earnings estimate of analysts had fallen by
about 14.8% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Frequency Therapeutics Inc shares had fallen by 16.7% this
quarter and lost 76.5% so far this year.
* The company reported a quarterly loss of $17.66 million.
* Wall Street's median 12-month price target for Frequency
Therapeutics Inc is $15.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and 1 "sell" or "strong sell." 
This summary was machine generated August 12 at 01:18 p.m.  ​All
figures in US dollars unless otherwise stated